Global Rapid Adenovirus Testing Market Research Report 2023
People with compromised immunity are at increased risk of serious illness caused by adenovirus infection. Adenovirus is a very common infection and according to WHO it is estimated to be responsible for 2% to 5% of all respiratory diseases. Several laboratory tests are available for the diagnosis of adenovirus eye infections. Adenovirus diagnostic tests detect the presence of double-stranded DNA virus found in adenoid tissue. Rapid diagnosis of human adenovirus (HAdV) infection has been achieved by PCR, will aid in treatment and diagnosis of adenovirus infections.
According to QYResearch’s new survey, global Rapid Adenovirus Testing market is projected to reach US$ 1506.1 million in 2029, increasing from US$ 836 million in 2022, with the CAGR of 8.8% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Rapid Adenovirus Testing market research.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Rapid Adenovirus Testing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
According to QYResearch’s new survey, global Rapid Adenovirus Testing market is projected to reach US$ 1506.1 million in 2029, increasing from US$ 836 million in 2022, with the CAGR of 8.8% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Rapid Adenovirus Testing market research.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Rapid Adenovirus Testing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
- Biopanda Reagents
- CTK Biotech
- Creative Diagnostics
- Intec PRODUCTS
- Biomerieux
- Accuquik
- SA Scientific
- F. Hoffmann-La Roche
- Diasorin
- Bio-Rad Laboratories
- QIAGEN
- Lateral Flow Immunochromatographic Assay
- Immunogold Assay
- PCR-Enzyme Hybridization Assay
- Hospitals
- Diagnostic Laboratories
- Others
- North America
- United States
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
1 RAPID ADENOVIRUS TESTING MARKET OVERVIEW
1.1 Product Overview and Scope of Rapid Adenovirus Testing
1.2 Rapid Adenovirus Testing Segment by Type
1.2.1 Global Rapid Adenovirus Testing Market Value Comparison by Type (2023-2029)
1.2.2 Lateral Flow Immunochromatographic Assay
1.2.3 Immunogold Assay
1.2.4 PCR-Enzyme Hybridization Assay
1.3 Rapid Adenovirus Testing Segment by Application
1.3.1 Global Rapid Adenovirus Testing Market Value by Application: (2023-2029)
1.3.2 Hospitals
1.3.3 Diagnostic Laboratories
1.3.4 Others
1.4 Global Rapid Adenovirus Testing Market Size Estimates and Forecasts
1.4.1 Global Rapid Adenovirus Testing Revenue 2018-2029
1.4.2 Global Rapid Adenovirus Testing Sales 2018-2029
1.4.3 Global Rapid Adenovirus Testing Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 RAPID ADENOVIRUS TESTING MARKET COMPETITION BY MANUFACTURERS
2.1 Global Rapid Adenovirus Testing Sales Market Share by Manufacturers (2018-2023)
2.2 Global Rapid Adenovirus Testing Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Rapid Adenovirus Testing Average Price by Manufacturers (2018-2023)
2.4 Global Rapid Adenovirus Testing Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Rapid Adenovirus Testing, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Rapid Adenovirus Testing, Product Type & Application
2.7 Rapid Adenovirus Testing Market Competitive Situation and Trends
2.7.1 Rapid Adenovirus Testing Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Rapid Adenovirus Testing Players Market Share by Revenue
2.7.3 Global Rapid Adenovirus Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 RAPID ADENOVIRUS TESTING RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global Rapid Adenovirus Testing Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Rapid Adenovirus Testing Global Rapid Adenovirus Testing Sales by Region: 2018-2029
3.2.1 Global Rapid Adenovirus Testing Sales by Region: 2018-2023
3.2.2 Global Rapid Adenovirus Testing Sales by Region: 2024-2029
3.3 Global Rapid Adenovirus Testing Global Rapid Adenovirus Testing Revenue by Region: 2018-2029
3.3.1 Global Rapid Adenovirus Testing Revenue by Region: 2018-2023
3.3.2 Global Rapid Adenovirus Testing Revenue by Region: 2024-2029
3.4 North America Rapid Adenovirus Testing Market Facts & Figures by Country
3.4.1 North America Rapid Adenovirus Testing Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Rapid Adenovirus Testing Sales by Country (2018-2029)
3.4.3 North America Rapid Adenovirus Testing Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Rapid Adenovirus Testing Market Facts & Figures by Country
3.5.1 Europe Rapid Adenovirus Testing Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Rapid Adenovirus Testing Sales by Country (2018-2029)
3.5.3 Europe Rapid Adenovirus Testing Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Rapid Adenovirus Testing Market Facts & Figures by Country
3.6.1 Asia Pacific Rapid Adenovirus Testing Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Rapid Adenovirus Testing Sales by Country (2018-2029)
3.6.3 Asia Pacific Rapid Adenovirus Testing Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Rapid Adenovirus Testing Market Facts & Figures by Country
3.7.1 Latin America Rapid Adenovirus Testing Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Rapid Adenovirus Testing Sales by Country (2018-2029)
3.7.3 Latin America Rapid Adenovirus Testing Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Rapid Adenovirus Testing Market Facts & Figures by Country
3.8.1 Middle East and Africa Rapid Adenovirus Testing Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Rapid Adenovirus Testing Sales by Country (2018-2029)
3.8.3 Middle East and Africa Rapid Adenovirus Testing Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 SEGMENT BY TYPE
4.1 Global Rapid Adenovirus Testing Sales by Type (2018-2029)
4.1.1 Global Rapid Adenovirus Testing Sales by Type (2018-2023)
4.1.2 Global Rapid Adenovirus Testing Sales by Type (2024-2029)
4.1.3 Global Rapid Adenovirus Testing Sales Market Share by Type (2018-2029)
4.2 Global Rapid Adenovirus Testing Revenue by Type (2018-2029)
4.2.1 Global Rapid Adenovirus Testing Revenue by Type (2018-2023)
4.2.2 Global Rapid Adenovirus Testing Revenue by Type (2024-2029)
4.2.3 Global Rapid Adenovirus Testing Revenue Market Share by Type (2018-2029)
4.3 Global Rapid Adenovirus Testing Price by Type (2018-2029)
5 SEGMENT BY APPLICATION
5.1 Global Rapid Adenovirus Testing Sales by Application (2018-2029)
5.1.1 Global Rapid Adenovirus Testing Sales by Application (2018-2023)
5.1.2 Global Rapid Adenovirus Testing Sales by Application (2024-2029)
5.1.3 Global Rapid Adenovirus Testing Sales Market Share by Application (2018-2029)
5.2 Global Rapid Adenovirus Testing Revenue by Application (2018-2029)
5.2.1 Global Rapid Adenovirus Testing Revenue by Application (2018-2023)
5.2.2 Global Rapid Adenovirus Testing Revenue by Application (2024-2029)
5.2.3 Global Rapid Adenovirus Testing Revenue Market Share by Application (2018-2029)
5.3 Global Rapid Adenovirus Testing Price by Application (2018-2029)
6 KEY COMPANIES PROFILED
6.1 Biopanda Reagents
6.1.1 Biopanda Reagents Corporation Information
6.1.2 Biopanda Reagents Description and Business Overview
6.1.3 Biopanda Reagents Rapid Adenovirus Testing Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Biopanda Reagents Rapid Adenovirus Testing Product Portfolio
6.1.5 Biopanda Reagents Recent Developments/Updates
6.2 CTK Biotech
6.2.1 CTK Biotech Corporation Information
6.2.2 CTK Biotech Description and Business Overview
6.2.3 CTK Biotech Rapid Adenovirus Testing Sales, Revenue and Gross Margin (2018-2023)
6.2.4 CTK Biotech Rapid Adenovirus Testing Product Portfolio
6.2.5 CTK Biotech Recent Developments/Updates
6.3 Creative Diagnostics
6.3.1 Creative Diagnostics Corporation Information
6.3.2 Creative Diagnostics Description and Business Overview
6.3.3 Creative Diagnostics Rapid Adenovirus Testing Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Creative Diagnostics Rapid Adenovirus Testing Product Portfolio
6.3.5 Creative Diagnostics Recent Developments/Updates
6.4 Intec PRODUCTS
6.4.1 Intec PRODUCTS Corporation Information
6.4.2 Intec PRODUCTS Description and Business Overview
6.4.3 Intec PRODUCTS Rapid Adenovirus Testing Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Intec PRODUCTS Rapid Adenovirus Testing Product Portfolio
6.4.5 Intec PRODUCTS Recent Developments/Updates
6.5 Biomerieux
6.5.1 Biomerieux Corporation Information
6.5.2 Biomerieux Description and Business Overview
6.5.3 Biomerieux Rapid Adenovirus Testing Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Biomerieux Rapid Adenovirus Testing Product Portfolio
6.5.5 Biomerieux Recent Developments/Updates
6.6 Accuquik
6.6.1 Accuquik Corporation Information
6.6.2 Accuquik Description and Business Overview
6.6.3 Accuquik Rapid Adenovirus Testing Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Accuquik Rapid Adenovirus Testing Product Portfolio
6.6.5 Accuquik Recent Developments/Updates
6.7 SA Scientific
6.6.1 SA Scientific Corporation Information
6.6.2 SA Scientific Description and Business Overview
6.6.3 SA Scientific Rapid Adenovirus Testing Sales, Revenue and Gross Margin (2018-2023)
6.4.4 SA Scientific Rapid Adenovirus Testing Product Portfolio
6.7.5 SA Scientific Recent Developments/Updates
6.8 F. Hoffmann-La Roche
6.8.1 F. Hoffmann-La Roche Corporation Information
6.8.2 F. Hoffmann-La Roche Description and Business Overview
6.8.3 F. Hoffmann-La Roche Rapid Adenovirus Testing Sales, Revenue and Gross Margin (2018-2023)
6.8.4 F. Hoffmann-La Roche Rapid Adenovirus Testing Product Portfolio
6.8.5 F. Hoffmann-La Roche Recent Developments/Updates
6.9 Diasorin
6.9.1 Diasorin Corporation Information
6.9.2 Diasorin Description and Business Overview
6.9.3 Diasorin Rapid Adenovirus Testing Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Diasorin Rapid Adenovirus Testing Product Portfolio
6.9.5 Diasorin Recent Developments/Updates
6.10 Bio-Rad Laboratories
6.10.1 Bio-Rad Laboratories Corporation Information
6.10.2 Bio-Rad Laboratories Description and Business Overview
6.10.3 Bio-Rad Laboratories Rapid Adenovirus Testing Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Bio-Rad Laboratories Rapid Adenovirus Testing Product Portfolio
6.10.5 Bio-Rad Laboratories Recent Developments/Updates
6.11 QIAGEN
6.11.1 QIAGEN Corporation Information
6.11.2 QIAGEN Rapid Adenovirus Testing Description and Business Overview
6.11.3 QIAGEN Rapid Adenovirus Testing Sales, Revenue and Gross Margin (2018-2023)
6.11.4 QIAGEN Rapid Adenovirus Testing Product Portfolio
6.11.5 QIAGEN Recent Developments/Updates
7 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
7.1 Rapid Adenovirus Testing Industry Chain Analysis
7.2 Rapid Adenovirus Testing Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Rapid Adenovirus Testing Production Mode & Process
7.4 Rapid Adenovirus Testing Sales and Marketing
7.4.1 Rapid Adenovirus Testing Sales Channels
7.4.2 Rapid Adenovirus Testing Distributors
7.5 Rapid Adenovirus Testing Customers
8 RAPID ADENOVIRUS TESTING MARKET DYNAMICS
8.1 Rapid Adenovirus Testing Industry Trends
8.2 Rapid Adenovirus Testing Market Drivers
8.3 Rapid Adenovirus Testing Market Challenges
8.4 Rapid Adenovirus Testing Market Restraints
9 RESEARCH FINDING AND CONCLUSION
10 METHODOLOGY AND DATA SOURCE
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Overview and Scope of Rapid Adenovirus Testing
1.2 Rapid Adenovirus Testing Segment by Type
1.2.1 Global Rapid Adenovirus Testing Market Value Comparison by Type (2023-2029)
1.2.2 Lateral Flow Immunochromatographic Assay
1.2.3 Immunogold Assay
1.2.4 PCR-Enzyme Hybridization Assay
1.3 Rapid Adenovirus Testing Segment by Application
1.3.1 Global Rapid Adenovirus Testing Market Value by Application: (2023-2029)
1.3.2 Hospitals
1.3.3 Diagnostic Laboratories
1.3.4 Others
1.4 Global Rapid Adenovirus Testing Market Size Estimates and Forecasts
1.4.1 Global Rapid Adenovirus Testing Revenue 2018-2029
1.4.2 Global Rapid Adenovirus Testing Sales 2018-2029
1.4.3 Global Rapid Adenovirus Testing Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 RAPID ADENOVIRUS TESTING MARKET COMPETITION BY MANUFACTURERS
2.1 Global Rapid Adenovirus Testing Sales Market Share by Manufacturers (2018-2023)
2.2 Global Rapid Adenovirus Testing Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Rapid Adenovirus Testing Average Price by Manufacturers (2018-2023)
2.4 Global Rapid Adenovirus Testing Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Rapid Adenovirus Testing, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Rapid Adenovirus Testing, Product Type & Application
2.7 Rapid Adenovirus Testing Market Competitive Situation and Trends
2.7.1 Rapid Adenovirus Testing Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Rapid Adenovirus Testing Players Market Share by Revenue
2.7.3 Global Rapid Adenovirus Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 RAPID ADENOVIRUS TESTING RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global Rapid Adenovirus Testing Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Rapid Adenovirus Testing Global Rapid Adenovirus Testing Sales by Region: 2018-2029
3.2.1 Global Rapid Adenovirus Testing Sales by Region: 2018-2023
3.2.2 Global Rapid Adenovirus Testing Sales by Region: 2024-2029
3.3 Global Rapid Adenovirus Testing Global Rapid Adenovirus Testing Revenue by Region: 2018-2029
3.3.1 Global Rapid Adenovirus Testing Revenue by Region: 2018-2023
3.3.2 Global Rapid Adenovirus Testing Revenue by Region: 2024-2029
3.4 North America Rapid Adenovirus Testing Market Facts & Figures by Country
3.4.1 North America Rapid Adenovirus Testing Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Rapid Adenovirus Testing Sales by Country (2018-2029)
3.4.3 North America Rapid Adenovirus Testing Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Rapid Adenovirus Testing Market Facts & Figures by Country
3.5.1 Europe Rapid Adenovirus Testing Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Rapid Adenovirus Testing Sales by Country (2018-2029)
3.5.3 Europe Rapid Adenovirus Testing Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Rapid Adenovirus Testing Market Facts & Figures by Country
3.6.1 Asia Pacific Rapid Adenovirus Testing Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Rapid Adenovirus Testing Sales by Country (2018-2029)
3.6.3 Asia Pacific Rapid Adenovirus Testing Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Rapid Adenovirus Testing Market Facts & Figures by Country
3.7.1 Latin America Rapid Adenovirus Testing Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Rapid Adenovirus Testing Sales by Country (2018-2029)
3.7.3 Latin America Rapid Adenovirus Testing Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Rapid Adenovirus Testing Market Facts & Figures by Country
3.8.1 Middle East and Africa Rapid Adenovirus Testing Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Rapid Adenovirus Testing Sales by Country (2018-2029)
3.8.3 Middle East and Africa Rapid Adenovirus Testing Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 SEGMENT BY TYPE
4.1 Global Rapid Adenovirus Testing Sales by Type (2018-2029)
4.1.1 Global Rapid Adenovirus Testing Sales by Type (2018-2023)
4.1.2 Global Rapid Adenovirus Testing Sales by Type (2024-2029)
4.1.3 Global Rapid Adenovirus Testing Sales Market Share by Type (2018-2029)
4.2 Global Rapid Adenovirus Testing Revenue by Type (2018-2029)
4.2.1 Global Rapid Adenovirus Testing Revenue by Type (2018-2023)
4.2.2 Global Rapid Adenovirus Testing Revenue by Type (2024-2029)
4.2.3 Global Rapid Adenovirus Testing Revenue Market Share by Type (2018-2029)
4.3 Global Rapid Adenovirus Testing Price by Type (2018-2029)
5 SEGMENT BY APPLICATION
5.1 Global Rapid Adenovirus Testing Sales by Application (2018-2029)
5.1.1 Global Rapid Adenovirus Testing Sales by Application (2018-2023)
5.1.2 Global Rapid Adenovirus Testing Sales by Application (2024-2029)
5.1.3 Global Rapid Adenovirus Testing Sales Market Share by Application (2018-2029)
5.2 Global Rapid Adenovirus Testing Revenue by Application (2018-2029)
5.2.1 Global Rapid Adenovirus Testing Revenue by Application (2018-2023)
5.2.2 Global Rapid Adenovirus Testing Revenue by Application (2024-2029)
5.2.3 Global Rapid Adenovirus Testing Revenue Market Share by Application (2018-2029)
5.3 Global Rapid Adenovirus Testing Price by Application (2018-2029)
6 KEY COMPANIES PROFILED
6.1 Biopanda Reagents
6.1.1 Biopanda Reagents Corporation Information
6.1.2 Biopanda Reagents Description and Business Overview
6.1.3 Biopanda Reagents Rapid Adenovirus Testing Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Biopanda Reagents Rapid Adenovirus Testing Product Portfolio
6.1.5 Biopanda Reagents Recent Developments/Updates
6.2 CTK Biotech
6.2.1 CTK Biotech Corporation Information
6.2.2 CTK Biotech Description and Business Overview
6.2.3 CTK Biotech Rapid Adenovirus Testing Sales, Revenue and Gross Margin (2018-2023)
6.2.4 CTK Biotech Rapid Adenovirus Testing Product Portfolio
6.2.5 CTK Biotech Recent Developments/Updates
6.3 Creative Diagnostics
6.3.1 Creative Diagnostics Corporation Information
6.3.2 Creative Diagnostics Description and Business Overview
6.3.3 Creative Diagnostics Rapid Adenovirus Testing Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Creative Diagnostics Rapid Adenovirus Testing Product Portfolio
6.3.5 Creative Diagnostics Recent Developments/Updates
6.4 Intec PRODUCTS
6.4.1 Intec PRODUCTS Corporation Information
6.4.2 Intec PRODUCTS Description and Business Overview
6.4.3 Intec PRODUCTS Rapid Adenovirus Testing Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Intec PRODUCTS Rapid Adenovirus Testing Product Portfolio
6.4.5 Intec PRODUCTS Recent Developments/Updates
6.5 Biomerieux
6.5.1 Biomerieux Corporation Information
6.5.2 Biomerieux Description and Business Overview
6.5.3 Biomerieux Rapid Adenovirus Testing Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Biomerieux Rapid Adenovirus Testing Product Portfolio
6.5.5 Biomerieux Recent Developments/Updates
6.6 Accuquik
6.6.1 Accuquik Corporation Information
6.6.2 Accuquik Description and Business Overview
6.6.3 Accuquik Rapid Adenovirus Testing Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Accuquik Rapid Adenovirus Testing Product Portfolio
6.6.5 Accuquik Recent Developments/Updates
6.7 SA Scientific
6.6.1 SA Scientific Corporation Information
6.6.2 SA Scientific Description and Business Overview
6.6.3 SA Scientific Rapid Adenovirus Testing Sales, Revenue and Gross Margin (2018-2023)
6.4.4 SA Scientific Rapid Adenovirus Testing Product Portfolio
6.7.5 SA Scientific Recent Developments/Updates
6.8 F. Hoffmann-La Roche
6.8.1 F. Hoffmann-La Roche Corporation Information
6.8.2 F. Hoffmann-La Roche Description and Business Overview
6.8.3 F. Hoffmann-La Roche Rapid Adenovirus Testing Sales, Revenue and Gross Margin (2018-2023)
6.8.4 F. Hoffmann-La Roche Rapid Adenovirus Testing Product Portfolio
6.8.5 F. Hoffmann-La Roche Recent Developments/Updates
6.9 Diasorin
6.9.1 Diasorin Corporation Information
6.9.2 Diasorin Description and Business Overview
6.9.3 Diasorin Rapid Adenovirus Testing Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Diasorin Rapid Adenovirus Testing Product Portfolio
6.9.5 Diasorin Recent Developments/Updates
6.10 Bio-Rad Laboratories
6.10.1 Bio-Rad Laboratories Corporation Information
6.10.2 Bio-Rad Laboratories Description and Business Overview
6.10.3 Bio-Rad Laboratories Rapid Adenovirus Testing Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Bio-Rad Laboratories Rapid Adenovirus Testing Product Portfolio
6.10.5 Bio-Rad Laboratories Recent Developments/Updates
6.11 QIAGEN
6.11.1 QIAGEN Corporation Information
6.11.2 QIAGEN Rapid Adenovirus Testing Description and Business Overview
6.11.3 QIAGEN Rapid Adenovirus Testing Sales, Revenue and Gross Margin (2018-2023)
6.11.4 QIAGEN Rapid Adenovirus Testing Product Portfolio
6.11.5 QIAGEN Recent Developments/Updates
7 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
7.1 Rapid Adenovirus Testing Industry Chain Analysis
7.2 Rapid Adenovirus Testing Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Rapid Adenovirus Testing Production Mode & Process
7.4 Rapid Adenovirus Testing Sales and Marketing
7.4.1 Rapid Adenovirus Testing Sales Channels
7.4.2 Rapid Adenovirus Testing Distributors
7.5 Rapid Adenovirus Testing Customers
8 RAPID ADENOVIRUS TESTING MARKET DYNAMICS
8.1 Rapid Adenovirus Testing Industry Trends
8.2 Rapid Adenovirus Testing Market Drivers
8.3 Rapid Adenovirus Testing Market Challenges
8.4 Rapid Adenovirus Testing Market Restraints
9 RESEARCH FINDING AND CONCLUSION
10 METHODOLOGY AND DATA SOURCE
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
LIST OF TABLES
Table 1. Global Rapid Adenovirus Testing Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Rapid Adenovirus Testing Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Rapid Adenovirus Testing Market Competitive Situation by Manufacturers in 2022
Table 4. Global Rapid Adenovirus Testing Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Rapid Adenovirus Testing Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Rapid Adenovirus Testing Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Rapid Adenovirus Testing Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Rapid Adenovirus Testing Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Rapid Adenovirus Testing, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Rapid Adenovirus Testing, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Rapid Adenovirus Testing, Product Type & Application
Table 12. Global Key Manufacturers of Rapid Adenovirus Testing, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Rapid Adenovirus Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rapid Adenovirus Testing as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Rapid Adenovirus Testing Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Rapid Adenovirus Testing Sales by Region (2018-2023) & (K Units)
Table 18. Global Rapid Adenovirus Testing Sales Market Share by Region (2018-2023)
Table 19. Global Rapid Adenovirus Testing Sales by Region (2024-2029) & (K Units)
Table 20. Global Rapid Adenovirus Testing Sales Market Share by Region (2024-2029)
Table 21. Global Rapid Adenovirus Testing Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Rapid Adenovirus Testing Revenue Market Share by Region (2018-2023)
Table 23. Global Rapid Adenovirus Testing Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Rapid Adenovirus Testing Revenue Market Share by Region (2024-2029)
Table 25. North America Rapid Adenovirus Testing Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Rapid Adenovirus Testing Sales by Country (2018-2023) & (K Units)
Table 27. North America Rapid Adenovirus Testing Sales by Country (2024-2029) & (K Units)
Table 28. North America Rapid Adenovirus Testing Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Rapid Adenovirus Testing Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Rapid Adenovirus Testing Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Rapid Adenovirus Testing Sales by Country (2018-2023) & (K Units)
Table 32. Europe Rapid Adenovirus Testing Sales by Country (2024-2029) & (K Units)
Table 33. Europe Rapid Adenovirus Testing Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Rapid Adenovirus Testing Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Rapid Adenovirus Testing Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Rapid Adenovirus Testing Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Rapid Adenovirus Testing Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Rapid Adenovirus Testing Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Rapid Adenovirus Testing Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Rapid Adenovirus Testing Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Rapid Adenovirus Testing Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Rapid Adenovirus Testing Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Rapid Adenovirus Testing Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Rapid Adenovirus Testing Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Rapid Adenovirus Testing Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Rapid Adenovirus Testing Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Rapid Adenovirus Testing Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Rapid Adenovirus Testing Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Rapid Adenovirus Testing Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Rapid Adenovirus Testing Sales (K Units) by Type (2018-2023)
Table 51. Global Rapid Adenovirus Testing Sales (K Units) by Type (2024-2029)
Table 52. Global Rapid Adenovirus Testing Sales Market Share by Type (2018-2023)
Table 53. Global Rapid Adenovirus Testing Sales Market Share by Type (2024-2029)
Table 54. Global Rapid Adenovirus Testing Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Rapid Adenovirus Testing Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Rapid Adenovirus Testing Revenue Market Share by Type (2018-2023)
Table 57. Global Rapid Adenovirus Testing Revenue Market Share by Type (2024-2029)
Table 58. Global Rapid Adenovirus Testing Price (US$/Unit) by Type (2018-2023)
Table 59. Global Rapid Adenovirus Testing Price (US$/Unit) by Type (2024-2029)
Table 60. Global Rapid Adenovirus Testing Sales (K Units) by Application (2018-2023)
Table 61. Global Rapid Adenovirus Testing Sales (K Units) by Application (2024-2029)
Table 62. Global Rapid Adenovirus Testing Sales Market Share by Application (2018-2023)
Table 63. Global Rapid Adenovirus Testing Sales Market Share by Application (2024-2029)
Table 64. Global Rapid Adenovirus Testing Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Rapid Adenovirus Testing Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Rapid Adenovirus Testing Revenue Market Share by Application (2018-2023)
Table 67. Global Rapid Adenovirus Testing Revenue Market Share by Application (2024-2029)
Table 68. Global Rapid Adenovirus Testing Price (US$/Unit) by Application (2018-2023)
Table 69. Global Rapid Adenovirus Testing Price (US$/Unit) by Application (2024-2029)
Table 70. Biopanda Reagents Corporation Information
Table 71. Biopanda Reagents Description and Business Overview
Table 72. Biopanda Reagents Rapid Adenovirus Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Biopanda Reagents Rapid Adenovirus Testing Product
Table 74. Biopanda Reagents Recent Developments/Updates
Table 75. CTK Biotech Corporation Information
Table 76. CTK Biotech Description and Business Overview
Table 77. CTK Biotech Rapid Adenovirus Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. CTK Biotech Rapid Adenovirus Testing Product
Table 79. CTK Biotech Recent Developments/Updates
Table 80. Creative Diagnostics Corporation Information
Table 81. Creative Diagnostics Description and Business Overview
Table 82. Creative Diagnostics Rapid Adenovirus Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Creative Diagnostics Rapid Adenovirus Testing Product
Table 84. Creative Diagnostics Recent Developments/Updates
Table 85. Intec PRODUCTS Corporation Information
Table 86. Intec PRODUCTS Description and Business Overview
Table 87. Intec PRODUCTS Rapid Adenovirus Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Intec PRODUCTS Rapid Adenovirus Testing Product
Table 89. Intec PRODUCTS Recent Developments/Updates
Table 90. Biomerieux Corporation Information
Table 91. Biomerieux Description and Business Overview
Table 92. Biomerieux Rapid Adenovirus Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Biomerieux Rapid Adenovirus Testing Product
Table 94. Biomerieux Recent Developments/Updates
Table 95. Accuquik Corporation Information
Table 96. Accuquik Description and Business Overview
Table 97. Accuquik Rapid Adenovirus Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Accuquik Rapid Adenovirus Testing Product
Table 99. Accuquik Recent Developments/Updates
Table 100. SA Scientific Corporation Information
Table 101. SA Scientific Description and Business Overview
Table 102. SA Scientific Rapid Adenovirus Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. SA Scientific Rapid Adenovirus Testing Product
Table 104. SA Scientific Recent Developments/Updates
Table 105. F. Hoffmann-La Roche Corporation Information
Table 106. F. Hoffmann-La Roche Description and Business Overview
Table 107. F. Hoffmann-La Roche Rapid Adenovirus Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. F. Hoffmann-La Roche Rapid Adenovirus Testing Product
Table 109. F. Hoffmann-La Roche Recent Developments/Updates
Table 110. Diasorin Corporation Information
Table 111. Diasorin Description and Business Overview
Table 112. Diasorin Rapid Adenovirus Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Diasorin Rapid Adenovirus Testing Product
Table 114. Diasorin Recent Developments/Updates
Table 115. Bio-Rad Laboratories Corporation Information
Table 116. Bio-Rad Laboratories Description and Business Overview
Table 117. Bio-Rad Laboratories Rapid Adenovirus Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Bio-Rad Laboratories Rapid Adenovirus Testing Product
Table 119. Bio-Rad Laboratories Recent Developments/Updates
Table 120. QIAGEN Corporation Information
Table 121. QIAGEN Description and Business Overview
Table 122. QIAGEN Rapid Adenovirus Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. QIAGEN Rapid Adenovirus Testing Product
Table 124. QIAGEN Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Rapid Adenovirus Testing Distributors List
Table 128. Rapid Adenovirus Testing Customers List
Table 129. Rapid Adenovirus Testing Market Trends
Table 130. Rapid Adenovirus Testing Market Drivers
Table 131. Rapid Adenovirus Testing Market Challenges
Table 132. Rapid Adenovirus Testing Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
Table 1. Global Rapid Adenovirus Testing Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Rapid Adenovirus Testing Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Rapid Adenovirus Testing Market Competitive Situation by Manufacturers in 2022
Table 4. Global Rapid Adenovirus Testing Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Rapid Adenovirus Testing Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Rapid Adenovirus Testing Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Rapid Adenovirus Testing Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Rapid Adenovirus Testing Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Rapid Adenovirus Testing, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Rapid Adenovirus Testing, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Rapid Adenovirus Testing, Product Type & Application
Table 12. Global Key Manufacturers of Rapid Adenovirus Testing, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Rapid Adenovirus Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rapid Adenovirus Testing as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Rapid Adenovirus Testing Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Rapid Adenovirus Testing Sales by Region (2018-2023) & (K Units)
Table 18. Global Rapid Adenovirus Testing Sales Market Share by Region (2018-2023)
Table 19. Global Rapid Adenovirus Testing Sales by Region (2024-2029) & (K Units)
Table 20. Global Rapid Adenovirus Testing Sales Market Share by Region (2024-2029)
Table 21. Global Rapid Adenovirus Testing Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Rapid Adenovirus Testing Revenue Market Share by Region (2018-2023)
Table 23. Global Rapid Adenovirus Testing Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Rapid Adenovirus Testing Revenue Market Share by Region (2024-2029)
Table 25. North America Rapid Adenovirus Testing Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Rapid Adenovirus Testing Sales by Country (2018-2023) & (K Units)
Table 27. North America Rapid Adenovirus Testing Sales by Country (2024-2029) & (K Units)
Table 28. North America Rapid Adenovirus Testing Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Rapid Adenovirus Testing Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Rapid Adenovirus Testing Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Rapid Adenovirus Testing Sales by Country (2018-2023) & (K Units)
Table 32. Europe Rapid Adenovirus Testing Sales by Country (2024-2029) & (K Units)
Table 33. Europe Rapid Adenovirus Testing Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Rapid Adenovirus Testing Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Rapid Adenovirus Testing Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Rapid Adenovirus Testing Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Rapid Adenovirus Testing Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Rapid Adenovirus Testing Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Rapid Adenovirus Testing Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Rapid Adenovirus Testing Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Rapid Adenovirus Testing Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Rapid Adenovirus Testing Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Rapid Adenovirus Testing Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Rapid Adenovirus Testing Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Rapid Adenovirus Testing Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Rapid Adenovirus Testing Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Rapid Adenovirus Testing Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Rapid Adenovirus Testing Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Rapid Adenovirus Testing Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Rapid Adenovirus Testing Sales (K Units) by Type (2018-2023)
Table 51. Global Rapid Adenovirus Testing Sales (K Units) by Type (2024-2029)
Table 52. Global Rapid Adenovirus Testing Sales Market Share by Type (2018-2023)
Table 53. Global Rapid Adenovirus Testing Sales Market Share by Type (2024-2029)
Table 54. Global Rapid Adenovirus Testing Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Rapid Adenovirus Testing Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Rapid Adenovirus Testing Revenue Market Share by Type (2018-2023)
Table 57. Global Rapid Adenovirus Testing Revenue Market Share by Type (2024-2029)
Table 58. Global Rapid Adenovirus Testing Price (US$/Unit) by Type (2018-2023)
Table 59. Global Rapid Adenovirus Testing Price (US$/Unit) by Type (2024-2029)
Table 60. Global Rapid Adenovirus Testing Sales (K Units) by Application (2018-2023)
Table 61. Global Rapid Adenovirus Testing Sales (K Units) by Application (2024-2029)
Table 62. Global Rapid Adenovirus Testing Sales Market Share by Application (2018-2023)
Table 63. Global Rapid Adenovirus Testing Sales Market Share by Application (2024-2029)
Table 64. Global Rapid Adenovirus Testing Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Rapid Adenovirus Testing Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Rapid Adenovirus Testing Revenue Market Share by Application (2018-2023)
Table 67. Global Rapid Adenovirus Testing Revenue Market Share by Application (2024-2029)
Table 68. Global Rapid Adenovirus Testing Price (US$/Unit) by Application (2018-2023)
Table 69. Global Rapid Adenovirus Testing Price (US$/Unit) by Application (2024-2029)
Table 70. Biopanda Reagents Corporation Information
Table 71. Biopanda Reagents Description and Business Overview
Table 72. Biopanda Reagents Rapid Adenovirus Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Biopanda Reagents Rapid Adenovirus Testing Product
Table 74. Biopanda Reagents Recent Developments/Updates
Table 75. CTK Biotech Corporation Information
Table 76. CTK Biotech Description and Business Overview
Table 77. CTK Biotech Rapid Adenovirus Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. CTK Biotech Rapid Adenovirus Testing Product
Table 79. CTK Biotech Recent Developments/Updates
Table 80. Creative Diagnostics Corporation Information
Table 81. Creative Diagnostics Description and Business Overview
Table 82. Creative Diagnostics Rapid Adenovirus Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Creative Diagnostics Rapid Adenovirus Testing Product
Table 84. Creative Diagnostics Recent Developments/Updates
Table 85. Intec PRODUCTS Corporation Information
Table 86. Intec PRODUCTS Description and Business Overview
Table 87. Intec PRODUCTS Rapid Adenovirus Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Intec PRODUCTS Rapid Adenovirus Testing Product
Table 89. Intec PRODUCTS Recent Developments/Updates
Table 90. Biomerieux Corporation Information
Table 91. Biomerieux Description and Business Overview
Table 92. Biomerieux Rapid Adenovirus Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Biomerieux Rapid Adenovirus Testing Product
Table 94. Biomerieux Recent Developments/Updates
Table 95. Accuquik Corporation Information
Table 96. Accuquik Description and Business Overview
Table 97. Accuquik Rapid Adenovirus Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Accuquik Rapid Adenovirus Testing Product
Table 99. Accuquik Recent Developments/Updates
Table 100. SA Scientific Corporation Information
Table 101. SA Scientific Description and Business Overview
Table 102. SA Scientific Rapid Adenovirus Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. SA Scientific Rapid Adenovirus Testing Product
Table 104. SA Scientific Recent Developments/Updates
Table 105. F. Hoffmann-La Roche Corporation Information
Table 106. F. Hoffmann-La Roche Description and Business Overview
Table 107. F. Hoffmann-La Roche Rapid Adenovirus Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. F. Hoffmann-La Roche Rapid Adenovirus Testing Product
Table 109. F. Hoffmann-La Roche Recent Developments/Updates
Table 110. Diasorin Corporation Information
Table 111. Diasorin Description and Business Overview
Table 112. Diasorin Rapid Adenovirus Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Diasorin Rapid Adenovirus Testing Product
Table 114. Diasorin Recent Developments/Updates
Table 115. Bio-Rad Laboratories Corporation Information
Table 116. Bio-Rad Laboratories Description and Business Overview
Table 117. Bio-Rad Laboratories Rapid Adenovirus Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Bio-Rad Laboratories Rapid Adenovirus Testing Product
Table 119. Bio-Rad Laboratories Recent Developments/Updates
Table 120. QIAGEN Corporation Information
Table 121. QIAGEN Description and Business Overview
Table 122. QIAGEN Rapid Adenovirus Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. QIAGEN Rapid Adenovirus Testing Product
Table 124. QIAGEN Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Rapid Adenovirus Testing Distributors List
Table 128. Rapid Adenovirus Testing Customers List
Table 129. Rapid Adenovirus Testing Market Trends
Table 130. Rapid Adenovirus Testing Market Drivers
Table 131. Rapid Adenovirus Testing Market Challenges
Table 132. Rapid Adenovirus Testing Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Product Picture of Rapid Adenovirus Testing
Figure 2. Global Rapid Adenovirus Testing Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Rapid Adenovirus Testing Market Share by Type in 2022 & 2029
Figure 4. Lateral Flow Immunochromatographic Assay Product Picture
Figure 5. Immunogold Assay Product Picture
Figure 6. PCR-Enzyme Hybridization Assay Product Picture
Figure 7. Global Rapid Adenovirus Testing Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Rapid Adenovirus Testing Market Share by Application in 2022 & 2029
Figure 9. Hospitals
Figure 10. Diagnostic Laboratories
Figure 11. Others
Figure 12. Global Rapid Adenovirus Testing Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Rapid Adenovirus Testing Market Size (2018-2029) & (US$ Million)
Figure 14. Global Rapid Adenovirus Testing Sales (2018-2029) & (K Units)
Figure 15. Global Rapid Adenovirus Testing Average Price (US$/Unit) & (2018-2029)
Figure 16. Rapid Adenovirus Testing Report Years Considered
Figure 17. Rapid Adenovirus Testing Sales Share by Manufacturers in 2022
Figure 18. Global Rapid Adenovirus Testing Revenue Share by Manufacturers in 2022
Figure 19. The Global 5 and 10 Largest Rapid Adenovirus Testing Players: Market Share by Revenue in 2022
Figure 20. Rapid Adenovirus Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 21. Global Rapid Adenovirus Testing Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 22. North America Rapid Adenovirus Testing Sales Market Share by Country (2018-2029)
Figure 23. North America Rapid Adenovirus Testing Revenue Market Share by Country (2018-2029)
Figure 24. United States Rapid Adenovirus Testing Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Canada Rapid Adenovirus Testing Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Europe Rapid Adenovirus Testing Sales Market Share by Country (2018-2029)
Figure 27. Europe Rapid Adenovirus Testing Revenue Market Share by Country (2018-2029)
Figure 28. Germany Rapid Adenovirus Testing Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. France Rapid Adenovirus Testing Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. U.K. Rapid Adenovirus Testing Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Italy Rapid Adenovirus Testing Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Russia Rapid Adenovirus Testing Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Asia Pacific Rapid Adenovirus Testing Sales Market Share by Region (2018-2029)
Figure 34. Asia Pacific Rapid Adenovirus Testing Revenue Market Share by Region (2018-2029)
Figure 35. China Rapid Adenovirus Testing Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Japan Rapid Adenovirus Testing Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. South Korea Rapid Adenovirus Testing Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. India Rapid Adenovirus Testing Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Australia Rapid Adenovirus Testing Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. China Taiwan Rapid Adenovirus Testing Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Indonesia Rapid Adenovirus Testing Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Thailand Rapid Adenovirus Testing Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Malaysia Rapid Adenovirus Testing Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Latin America Rapid Adenovirus Testing Sales Market Share by Country (2018-2029)
Figure 45. Latin America Rapid Adenovirus Testing Revenue Market Share by Country (2018-2029)
Figure 46. Mexico Rapid Adenovirus Testing Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Brazil Rapid Adenovirus Testing Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Argentina Rapid Adenovirus Testing Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Middle East & Africa Rapid Adenovirus Testing Sales Market Share by Country (2018-2029)
Figure 50. Middle East & Africa Rapid Adenovirus Testing Revenue Market Share by Country (2018-2029)
Figure 51. Turkey Rapid Adenovirus Testing Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Saudi Arabia Rapid Adenovirus Testing Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. UAE Rapid Adenovirus Testing Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Global Sales Market Share of Rapid Adenovirus Testing by Type (2018-2029)
Figure 55. Global Revenue Market Share of Rapid Adenovirus Testing by Type (2018-2029)
Figure 56. Global Rapid Adenovirus Testing Price (US$/Unit) by Type (2018-2029)
Figure 57. Global Sales Market Share of Rapid Adenovirus Testing by Application (2018-2029)
Figure 58. Global Revenue Market Share of Rapid Adenovirus Testing by Application (2018-2029)
Figure 59. Global Rapid Adenovirus Testing Price (US$/Unit) by Application (2018-2029)
Figure 60. Rapid Adenovirus Testing Value Chain
Figure 61. Rapid Adenovirus Testing Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Figure 1. Product Picture of Rapid Adenovirus Testing
Figure 2. Global Rapid Adenovirus Testing Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Rapid Adenovirus Testing Market Share by Type in 2022 & 2029
Figure 4. Lateral Flow Immunochromatographic Assay Product Picture
Figure 5. Immunogold Assay Product Picture
Figure 6. PCR-Enzyme Hybridization Assay Product Picture
Figure 7. Global Rapid Adenovirus Testing Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Rapid Adenovirus Testing Market Share by Application in 2022 & 2029
Figure 9. Hospitals
Figure 10. Diagnostic Laboratories
Figure 11. Others
Figure 12. Global Rapid Adenovirus Testing Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Rapid Adenovirus Testing Market Size (2018-2029) & (US$ Million)
Figure 14. Global Rapid Adenovirus Testing Sales (2018-2029) & (K Units)
Figure 15. Global Rapid Adenovirus Testing Average Price (US$/Unit) & (2018-2029)
Figure 16. Rapid Adenovirus Testing Report Years Considered
Figure 17. Rapid Adenovirus Testing Sales Share by Manufacturers in 2022
Figure 18. Global Rapid Adenovirus Testing Revenue Share by Manufacturers in 2022
Figure 19. The Global 5 and 10 Largest Rapid Adenovirus Testing Players: Market Share by Revenue in 2022
Figure 20. Rapid Adenovirus Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 21. Global Rapid Adenovirus Testing Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 22. North America Rapid Adenovirus Testing Sales Market Share by Country (2018-2029)
Figure 23. North America Rapid Adenovirus Testing Revenue Market Share by Country (2018-2029)
Figure 24. United States Rapid Adenovirus Testing Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Canada Rapid Adenovirus Testing Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Europe Rapid Adenovirus Testing Sales Market Share by Country (2018-2029)
Figure 27. Europe Rapid Adenovirus Testing Revenue Market Share by Country (2018-2029)
Figure 28. Germany Rapid Adenovirus Testing Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. France Rapid Adenovirus Testing Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. U.K. Rapid Adenovirus Testing Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Italy Rapid Adenovirus Testing Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Russia Rapid Adenovirus Testing Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Asia Pacific Rapid Adenovirus Testing Sales Market Share by Region (2018-2029)
Figure 34. Asia Pacific Rapid Adenovirus Testing Revenue Market Share by Region (2018-2029)
Figure 35. China Rapid Adenovirus Testing Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Japan Rapid Adenovirus Testing Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. South Korea Rapid Adenovirus Testing Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. India Rapid Adenovirus Testing Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Australia Rapid Adenovirus Testing Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. China Taiwan Rapid Adenovirus Testing Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Indonesia Rapid Adenovirus Testing Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Thailand Rapid Adenovirus Testing Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Malaysia Rapid Adenovirus Testing Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Latin America Rapid Adenovirus Testing Sales Market Share by Country (2018-2029)
Figure 45. Latin America Rapid Adenovirus Testing Revenue Market Share by Country (2018-2029)
Figure 46. Mexico Rapid Adenovirus Testing Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Brazil Rapid Adenovirus Testing Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Argentina Rapid Adenovirus Testing Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Middle East & Africa Rapid Adenovirus Testing Sales Market Share by Country (2018-2029)
Figure 50. Middle East & Africa Rapid Adenovirus Testing Revenue Market Share by Country (2018-2029)
Figure 51. Turkey Rapid Adenovirus Testing Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Saudi Arabia Rapid Adenovirus Testing Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. UAE Rapid Adenovirus Testing Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Global Sales Market Share of Rapid Adenovirus Testing by Type (2018-2029)
Figure 55. Global Revenue Market Share of Rapid Adenovirus Testing by Type (2018-2029)
Figure 56. Global Rapid Adenovirus Testing Price (US$/Unit) by Type (2018-2029)
Figure 57. Global Sales Market Share of Rapid Adenovirus Testing by Application (2018-2029)
Figure 58. Global Revenue Market Share of Rapid Adenovirus Testing by Application (2018-2029)
Figure 59. Global Rapid Adenovirus Testing Price (US$/Unit) by Application (2018-2029)
Figure 60. Rapid Adenovirus Testing Value Chain
Figure 61. Rapid Adenovirus Testing Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
